Outset Medical, Inc.
For the period ended Dec 31, 2025. Filed Feb 13, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 13, 2026
OM$4.12-2.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. Form 10-K Summary
None.
Exhibit Index
| Incorporation by Reference | |||||
|---|---|---|---|---|---|
| ExhibitNumber | Description | Form | File No. | Exhibit | Filing Date |
| 3.1 | Amended and Restated Certificate of Incorporation of Outset Medical, Inc. | S-1/A | 333-248225 | 3.1 | September 9, 2020 |
| 3.2 | Amended and Restated Bylaws of Outset Medical, Inc. | S-1/A | 333-248225 | 3.2 | September 9, 2020 |
| 3.3 | Amendment No. 1 to Amended and Restated Bylaws of Outset Medical, Inc., dated January 23, 2025 | 8-K | 001-39513 | 3.1 | January 24, 2025 |
| 3.4 | Certificate of Designation of Preferences, Rights and Limitations of Series A Non-Voting Convertible Preferred Stock | 8-K | 001-39513 | 3.1 | January 8, 2025 |
| 3.5 | Certificate of Correction of the Certificate of Designation of Preferences, Rights and Limitations of Series A Non-Voting Convertible Preferred Stock | 8-K | 001-39513 | 3.1 | March 11, 2025 |
| 3.6 | Certificate of Amendment of Amended and Restated Certificate of Incorporation of Outset Medical, Inc. | 8-K | 001-39513 | 3.1 | March 20, 2025 |
| 4.1 | Form of Common Stock Certificate | S-1/A | 333-248225 | 4.1 | September 9, 2020 |
| 4.2 | Warrant Certificate, dated January 8, 2025, issued by Outset Medical, Inc. to Perceptive Credit Holdings IV, LP | 8-K | 001-39513 | 4.1 | January 8, 2025 |
| 4.3* | Description of Outset Medical, Inc.’s Securities Registered Pursuant to Section 12 of the Exchange Act | ||||
| 10.1† | Form of Indemnification Agreement | S-1/A | 333-248225 | 10.1 | September 9, 2020 |
| 10.2† | Outset Medical, Inc. 2010 Equity Incentive Plan and related form agreements | S-1 | 333-248225 | 10.2 | August 21, 2020 |
| 10.3† | Outset Medical, Inc. 2019 Equity Incentive Plan and related form agreements | S-1 | 333-248225 | 10.3 | August 21, 2020 |
| 10.4† | Outset Medical, Inc. 2020 Equity Incentive Plan, as amended and restated | 10-Q | 001-39513 | 10.1 | August 7, 2025 |
| 10.5† | Form of Stock Option Grant Notice and Option Agreement for Outset Medical, Inc. 2020 Equity Incentive Plan | 10-K | 001-39513 | 10.5 | March 22, 2021 |
| 10.6† | Form of Restricted Stock Unit Award Grant Notice and Award Agreement for Outset Medical, Inc. 2020 Equity Incentive Plan | 10-K | 001-39513 | 10.6 | March 22, 2021 |
| 10.7† | Form of Restricted Stock Award Grant Notice and Award Agreement for Outset Medical, Inc. 2020 Equity Incentive Plan | 10-K | 001-39513 | 10.7 | March 22, 2021 |
| 10.8† | Form of Performance Stock Unit Award Grant Notice and Award Agreement for Outset Medical, Inc. 2020 Equity Incentive Plan | 10-K | 001-39513 | 10.8 | March 22, 2021 |
| 10.9†* | Outset Medical, Inc. Employee Stock Purchase Plan, as amended and restated | ||||
| 10.10†* | Outset Medical, Inc. Inducement Plan | ||||
| 10.11† | Employment Agreement by and between Outset Medical and Leslie Trigg, dated as of February 23, 2015 | S-1 | 333-248225 | 10.6 | August 21, 2020 |
| 10.12† | Offer Letter between Outset Medical, Inc. and Renee Gaeta, dated as of May 31, 2025 | 10-Q | 001-39513 | 10.3 | August 7, 2025 |
| 10.13 | Form of Amended and Restated Change in Control and Severance Agreement for Chief Executive Officer | 10-K | 001-39513 | 10.11 | February 21, 2024 |
| 10.14 | Form of Amended and Restated Change in Control and Severance Agreement for non-Chief Executive Officer executive officers | 10-K | 001-39513 | 10.12 | February 21, 2024 |
| 10.15# | Lease by and between WH Silicon Valley IV LP and Outset Medical, Inc., dated as of September 19, 2019 | S-1 | 333-248225 | 10.10 | August 21, 2020 |
| 10.16# | Sublease Agreement by and among Inmobiliaria IAMSA, S.A. de C.V. (Sublessor), Baja Fur S.A. de C.V. (Sublessee) and Outset Medical, Inc. (Guarantor), dated as of May 5, 2020 | S-1 | 333-248225 | 10.11 | August 21, 2020 |
| 10.17# | First Amendment Agreement by and among Inmobiliaria IAMSA, S.A. de C.V. (Sublessor), Baja Fur S.A. de C.V. (Sublessee) and Outset Medical, Inc. (Guarantor), dated as of June 26, 2020 | S-1 | 333-248225 | 10.12 | August 21, 2020 |
| 10.18# | Guaranty by and between Inmobiliaria IAMSA, S.A. de C.V. and Outset Medical, Inc dated as of May 6, 2020 | S-1 | 333-248225 | 10.13 | August 21, 2020 |
| 10.19# | Manufacturing Services Agreement by and between TACNA Services, Inc. and Outset Medical, Inc. dated as of January 15, 2020 | S-1 | 333-248225 | 10.17 | August 21, 2020 |
| 10.20# | Amendment to Manufacturing Services Agreement by and between TACNA Services, Inc. and Outset Medical, Inc. effective as of February 12, 2024 | 10-Q | 001-39513 | 10.2 | May 9, 2024 |
| 10.21# | Authorized Reseller Agreement by and between SDV Office Systems, LLC dba SDV Medical and Outset Medical, Inc. dated as of October 14, 2019 | S-1 | 333-248225 | 10.18 | August 21, 2020 |
| 10.22# | Amendment 1 to the Authorized Reseller Agreement by and between SDV Office Systems, LLC dba SDV Medical and Outset Medical, Inc. dated as of March 26, 2020 | S-1 | 333-248225 | 10.19 | August 21, 2020 |
| 10.23# | Amendment 2 to the Authorized Reseller Agreement by and between SDV Office Systems, LLC dba SDV Medical and Outset Medical, Inc. dated as of May 6, 2020 | S-1 | 333-248225 | 10.20 | August 21, 2020 |
| 10.24# | Purchasing Agreement by and between HCA Management Services, L.P. and Outset Medical, Inc. dated as of May 1, 2020 | S-1 | 333-248225 | 10.21 | August 21, 2020 |
| 10.25# | Credit Agreement and Guaranty, dated as of January 3, 2025, by and among Outset Medical, Inc. as the borrower and Perceptive Credit Holdings IV, LP, as the initial lender and the administrative agent | 8-K | 001-39513 | 10.4 | January 6, 2025 |
| 10.26 | Form of Securities Purchase Agreement, dated as of January 3, 2025 between Outset Medical, Inc. and certain of the Investors | 8-K | 001-39513 | 10.1 | January 6, 2025 |
| 10.27 | Form of Securities Purchase Agreement, dated as of January 3, 2025 between Outset Medical, Inc. and certain members of management and certain directors | 8-K | 001-39513 | 10.2 | January 6, 2025 |
| 10.28 | Form of Registration Rights Agreement, dated as of January 3, 2025 between Outset Medical, Inc. and the Investors | 8-K | 001-39513 | 10.3 | January 6, 2025 |
| 19.1 | Outset Medical, Inc. Insider Trading Policy | 10-K | 001-39513 | 19.1 | February 28, 2025 |
| 23.1* | Consent of KPMG LLP, independent registered public accounting firm | ||||
| 24.1* | Power of Attorney (included on the signature page) | ||||
| 31.1* | Certification of Principal Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) of the Exchange Act, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | ||||
| 31.2* | Certification of Principal Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) of the Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | ||||
| 32.1* | Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | ||||
| 97.1 | Outset Medical, Inc. Policy on Recoupment of Incentive Compensation | 10-K | 001-39513 | 97.1 | February 21, 2024 |
| 101.INS | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | ||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema with Embedded Linkbase Documents | ||||
| 104 | Cover Page formatted as inline XBRL and contained in Exhibits 101 | ||||
- Filed herewith
† Indicates a management contract or compensatory plan or arrangement.
Portions of the exhibit have been or will be excluded because it is both not material and is the type of information that the registrant treats as private or confidential.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.